KLOW peptide blends
Figure 2 GLP-1 and GLP-1 Analogs In patients with T2D, GLP-1 and GLP-1 analogs were shown to improve cardiovascular-risk profiles, by reducing body fat content, blood pressure, circulating lipids, and inflammatory markers ( DPP-4 Inhibitors DPP-4 activity is markedly increased in obese subjects and in animal models of obesity ( Nonetheless, DPP-4 inhibitors improve cardiovascular outcomes by modulating innate and adaptive immunity and suppression of the NLRP3 inflammasome, a multiprotein complex involved in caspase-1 activation and downstream maturation of pro-inflammatory cytokines, TLR4 and IL-1 in human macrophages ( In summary, these observations underline the tight interrelation of endocrine signaling and immune responses and, furthermore, indicate common disease mechanism for metabolic and immune-mediated disorders
When you dont take in enough fluids, your skin can be affected
Ensuring your body has a baseline of micronutrients can help support overall energy levels and neurological function, potentially reducing the frequency of lightheaded spells
GLP-1s are designed for long-term management of a chronic condition (obesity)
I love to support patients to recover from stress and toxins in my practice